GlassScriptPhysician profile
Cynthia Lullo
NPI 1063063584
$5,559.52
in general payments reported to CMS, 2019-2025
37 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,092 · 2022: $1,105 · 2023: $886 · 2024: $1,246 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,362.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $1,119.81 | 2021-2025 | Korlym |
| Lilly USA, LLC | $483.79 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $389.38 | 2022-2025 | |
| Amgen INC. | $339.98 | 2021-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $270.95 | 2023-2025 | |
| Glaxosmithkline, LLC. | $263.16 | 2021-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Teva Pharmaceuticals USA, INC. | $222.20 | 2024-2025 | Uzedy |
| Novo Nordisk INC | $221.73 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.16 | 2021-2025 | Jardiance, Synjardy |
| Indivior INC. | $202.18 | 2021-2025 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $200.75 | 2021-2024 | Caplyta |
| Esperion Therapeutics, INC. | $170.51 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $156.76 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Sanofi-Aventis U.S. LLC | $153.22 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $146.17 | 2022-2024 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Lullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.